Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5152
Peer-review started: April 14, 2021
First decision: June 3, 2021
Revised: June 14, 2021
Accepted: July 15, 2021
Article in press: July 15, 2021
Published online: August 21, 2021
Processing time: 126 Days and 5.8 Hours
Helicobacter pylori (H. pylori) infects approximately 50% of all humans globally. Persistent H. pylori infection causes multiple gastric and extragastric diseases, indicating the importance of early diagnosis and timely treatment. H. pylori eradication produces dramatic changes in the gastric mucosa, resulting in restored function. Consequently, to better understand the importance of H. pylori eradication and clarify the subsequent recovery of gastric mucosal functions after eradication, we summarize histological, endoscopic, and gastric microbiota changes to assess the therapeutic effects on the gastric mucosa.
Core Tip: Eradication of Helicobacter pylori (H. pylori) is important. Multiple gastrointestinal diseases and extragastric diseases would emerge if H. pylori infection persists, whereas they would improve after H. pylori eradication. Thus, H. pylori eradication produces dramatic changes in the gastric mucosa. This review highlights the most recent literature and presents a comprehensive evaluation about the impact of H. pylori eradication on the gastric mucosa.
